Bristol-Myers Squibb Co
Bristol-Myers Squibb's GHG Emissions Data Preview
In 2024, Bristol-Myers Squibb completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Bristol-Myers Squibb has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Bristol-Myers Squibb's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Bristol-Myers Squibb amounted to 356,562 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Bristol-Myers Squibb decreased by 2.94%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Bristol-Myers Squibb's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Bristol-Myers Squibb's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Bristol-Myers Squibb were 206,726 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Bristol-Myers Squibb reduced its Scope 1 emissions over time?
Since 2018, Bristol-Myers Squibb's Scope 1 emissions have increased by 1.48%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Bristol-Myers Squibb's Scope 1 emissions remained relatively stable, indicating that Bristol-Myers Squibb's emissions have plateaued with no significant change in its operational footprint.
What are Bristol-Myers Squibb's Scope 2 emissions?
In 2024, Bristol-Myers Squibb reported Scope 2 greenhouse gas (GHG) emissions of 104,649 tCOâ‚‚e using the market-based method, and 149,836 tCOâ‚‚e using the location-based method.
Has Bristol-Myers Squibb reduced its Scope 2 emissions over time?
Compared to the previous year (2023), Bristol-Myers Squibb's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Bristol-Myers Squibb 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Bristol-Myers Squibb use for Scope 2 reporting?
In 2024, Bristol-Myers Squibb reported its Scope 2 emissions using the market-based method and using the location-based method.
Bristol-Myers Squibb's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
- Total Scope 2 (Unspecified Calculation Method)
Insights into Bristol-Myers Squibb's Value Chain Emissions
In 2024, Bristol-Myers Squibb reported 1,700,746 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of Bristol-Myers Squibb includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Bristol-Myers Squibb's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Bristol-Myers Squibb's Scope 3 emissions?
In 2024, Bristol-Myers Squibb reported total Scope 3 emissions of 1,700,746 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 93.44% of these emissions originated from upstream activities such as purchased goods and capital goods, while 6.56% came from downstream activities like product use, distribution, and end-of-life treatment.
Has Bristol-Myers Squibb reduced its Scope 3 emissions over time?
Since 2018, Bristol-Myers Squibb's Scope 3 emissions have increased by 2,765.14%, reflecting a rising long-term trend in Scope 3 emissions over time.
Compared to the previous year (2023), Bristol-Myers Squibb's Scope 3 emissions remained relatively stable, indicating that Bristol-Myers Squibb 's emissions have plateaued with no significant change in its value chain footprint.
What categories of Scope 3 emissions does Bristol-Myers Squibb disclose?
In 2024, Bristol-Myers Squibb reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Bristol-Myers Squibb's Scope 3 emissions?
In 2024, the largest contributors to Bristol-Myers Squibb's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 1,218,474 tCOâ‚‚e (71.64%)
- Upstream Transportation and Distribution (Cat. 4): 149,090 tCOâ‚‚e (8.77%)
- Investments (Cat. 15): 108,127 tCOâ‚‚e (6.36%)
Bristol-Myers Squibb's Scope 3 Emissions by Categories
Insights into Bristol-Myers Squibb's Total Carbon Footprint
In 2024, Bristol-Myers Squibb reported a total carbon footprint of 2,057,308 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 2.88% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to Bristol-Myers Squibb's total carbon footprint was Scope 3 emissions, accounting for 82.67% of the company's total carbon footprint, followed by Scope 1 emissions at 10.05%.